Cargando…
Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
In the present studies we have used the RIF-1 tumour in C3H mice to try to identify the mechanism(s) responsible for the enhancement of melphalan (L-PAM) induced tumour cell killing by the 2-nitroimidazole misonidazole (MISO). Most of this work was done with a single large dose of MISO (750 mg kg-1)...
Autores principales: | Horsman, M. R., Evans, J. W., Brown, J. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976784/ https://www.ncbi.nlm.nih.gov/pubmed/6466544 |
Ejemplares similares
-
Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985) -
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
por: Murray, D., et al.
Publicado: (1983) -
The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987) -
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
por: McNally, N. J.
Publicado: (1982) -
Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
por: Smith, E., et al.
Publicado: (1982)